Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (PACTR202508856741773) titled 'Djibouti in-vivo therapeutic efficacy study -2024' on Aug. 8.
Study Type: Interventional
Study Design:
Single Group,Non-randomised
Primary Sponsor: Armauer Hansen Research Institute
Condition:
Malaria
Recruitment Status: Not Recruiting
Phase: Phase-4
Date of First Enrollment: 30/03/2024
Target Sample Size: 88
Countries of Recruitment:
Djibouti
Djibouti
Djibouti
To know more, visit https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=27315
Disclaimer: Curated by HT Syndication....